Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Literature DB >> 13679531

Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Gregory L Kearns¹, Susan M Abdel-Rahman, Sarah W Alander, Douglas L Blowey, J Steven Leeder, Ralph E Kauffman.

Abstract

Entities: Species

Mesh：

Substances：

Year: 2003 PMID： 13679531 DOI： 10.1056/NEJMra035092

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

611 in total

Review 1. Azole interactions with multidrug therapy in pediatric oncology.

Authors: Antonio Ruggiero; Roberta Arena; Andrea Battista; Daniela Rizzo; Giorgio Attinà; Riccardo Riccardi
Journal: Eur J Clin Pharmacol Date: 2012-06-02 Impact factor: 2.953

2. Methodological and Ethical Issues in Pediatric Medication Safety Research.

Authors: Delesha Carpenter; Daniel Gonzalez; George Retsch-Bogart; Betsy Sleath; Benjamin Wilfond
Journal: Pediatrics Date: 2017-08-04 Impact factor: 7.124

Review 3. A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.

Authors: Marilena M DeMayo; Yun Ju C Song; Ian B Hickie; Adam J Guastella
Journal: Paediatr Drugs Date: 2017-10 Impact factor: 3.022

4. Developmental Pharmacokinetics and Age-Appropriate Dosing Design of Milrinone in Neonates and Infants with Acute Kidney Injury Following Cardiac Surgery.

Authors: Tomoyuki Mizuno; Katja M Gist; Zhiqian Gao; Michael F Wempe; Jeffrey Alten; David S Cooper; Stuart L Goldstein; Alexander A Vinks
Journal: Clin Pharmacokinet Date: 2019-06 Impact factor: 6.447

Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Review 1. Azole interactions with multidrug therapy in pediatric oncology.

2. Methodological and Ethical Issues in Pediatric Medication Safety Research.

Review 3. A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.

4. Developmental Pharmacokinetics and Age-Appropriate Dosing Design of Milrinone in Neonates and Infants with Acute Kidney Injury Following Cardiac Surgery.

Review 5. Efficacy and Safety of Ibuprofen in Infants Aged Between 3 and 6 Months.

6. Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure.

7. Drug labeling and exposure in neonates.

Review 8. How to optimize the evaluation and use of antibiotics in neonates.

9. The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children.

10. Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients.